Volume 1, Issue 1, p1-24
Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.
Therapeutic compliance has been defined as the degree to which the behaviour of a person corresponds with the recommendations of the health professional .Arch Pharmacol Ther, 2019, Volume 1, Issue 1, p1-7 | DOI: 10.33696/Pharmacol.1.001
Onion has been a very useful vegetable for human. The organic molecules present in onion are extremely diverse and exert numerous pharmacological pathways to prevent diseasesArch Pharmacol Ther, 2019, Volume 1, Issue 1, p14-16 | DOI: 10.33696/Pharmacol.1.003
Appropriate medicinal drugs can save life of any patientat risk with high mortality and morbidity. All ongoingcosts and benefits are covered mainly by the health insurance, the pharmaceutical, and alternative medicine industry.Arch Pharmacol Ther, 2019, Volume 1, Issue 1, p17-18 | DOI: 10.33696/Pharmacol.1.004
Nearly 80% of people with diabetes live in low and middle-income countries. It increases healthcare use and expenditure and imposes a huge economic burden on the healthcare systemsArch Pharmacol Ther, 2019, Volume 1, Issue 1, p8-13 | DOI: 10.33696/Pharmacol.1.002
Molecular Detection of Plasmid - Mediated Quinolone Resistant Genes in Uropathogenic E. coli from Tertiary Referral Hospital in Tehran , Iran
Urinary Tract Infection (UTI) due to Escherichia coli is the most common bacterial infection. Fluoroquinolones are commonly used for the treatment of UTI because isolated microorganisms are frequently resistant to aminopenicillins and trimethoprim- sulfamethoxazole and fluoroquinolones are given orally .Arch Pharmacol Ther, 2019, Volume 1, Issue 1, p19-24 | DOI: doi.org/10.33696/Pharmacol.1.005
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.